Edmond DE Rothschild Holding S.A. increased its stake in Clarivate Plc (NYSE:CLVT – Free Report) by 33.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,492,760 shares of the company’s stock after purchasing an additional 1,632,930 shares during the period. Edmond DE Rothschild Holding S.A. owned 0.91% of Clarivate worth $32,983,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of CLVT. Perpetual Ltd raised its position in shares of Clarivate by 24.6% during the fourth quarter. Perpetual Ltd now owns 9,192,680 shares of the company’s stock worth $46,699,000 after acquiring an additional 1,816,936 shares during the last quarter. Cerity Partners LLC raised its holdings in Clarivate by 82.5% during the 3rd quarter. Cerity Partners LLC now owns 202,204 shares of the company’s stock worth $1,436,000 after purchasing an additional 91,384 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Clarivate by 112.9% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,040,426 shares of the company’s stock valued at $7,387,000 after purchasing an additional 551,838 shares during the period. Verition Fund Management LLC lifted its position in Clarivate by 707.5% during the 3rd quarter. Verition Fund Management LLC now owns 157,540 shares of the company’s stock valued at $1,119,000 after purchasing an additional 138,031 shares during the period. Finally, GAMMA Investing LLC boosted its stake in shares of Clarivate by 161.4% in the 4th quarter. GAMMA Investing LLC now owns 5,256 shares of the company’s stock valued at $27,000 after purchasing an additional 3,245 shares during the last quarter. Institutional investors and hedge funds own 85.72% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada restated a “sector perform” rating and issued a $6.00 price objective on shares of Clarivate in a report on Thursday, February 20th.
Clarivate Trading Down 3.1 %
NYSE:CLVT opened at $3.97 on Monday. The firm has a market capitalization of $2.73 billion, a price-to-earnings ratio of -4.13 and a beta of 1.28. Clarivate Plc has a 1-year low of $3.90 and a 1-year high of $7.77. The business’s 50-day moving average price is $4.68 and its two-hundred day moving average price is $5.41. The company has a current ratio of 0.87, a quick ratio of 0.88 and a debt-to-equity ratio of 0.88.
Clarivate declared that its board has authorized a stock repurchase program on Monday, December 16th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the company to reacquire up to 12.8% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.
Clarivate Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
See Also
- Five stocks we like better than Clarivate
- Which Wall Street Analysts are the Most Accurate?
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- The How And Why of Investing in Oil Stocks
- MarketBeat Week in Review – 03/24 – 03/28
- How to invest in marijuana stocks in 7 steps
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.